Elevated MCU Expression by CaMKIIδB Limits Pathological Cardiac Remodeling

Area of Science:

• Cardiovascular Biology
• Mitochondrial Physiology
• Cardiac Pathophysiology

Background:

• Calcium (Ca2+) is crucial for cellular energy metabolism.
• Mitochondrial Ca2+ overload contributes to heart failure by damaging cardiomyocytes.
• The mitochondrial Ca2+ uniporter (MCU) plays a key role in regulating mitochondrial Ca2+ uptake.

Purpose of the Study:

• To investigate the regulation of the mitochondrial Ca2+ uniporter (MCU) under chronic stress.
• To determine the role of MCU in pathological cardiac remodeling induced by beta-adrenergic stimulation.
• To elucidate the signaling pathways involved in MCU regulation during cardiac stress.

Main Methods:

• Utilized MCU knockout and transgenic mouse models.
• Administered isoproterenol (ISO) to induce chronic cardiac stress in vivo and in vitro.
• Assessed cardiac function, hypertrophy, fibrosis, and cardiomyocyte death.
• Employed adenovirus-mediated gene manipulation in cultured cardiomyocytes.

Main Results:

• Isoproterenol (ISO) increased MCU levels and mitochondrial Ca2+ uptake in cardiac mitochondria.
• Mice lacking MCU exhibited exacerbated cardiac hypertrophy, fibrosis, and cardiomyocyte death upon ISO treatment.
• Overexpression of MCU preserved cardiac function and prevented ISO-induced heart remodeling.
• Identified the Ca2+/calmodulin kinase II deltaB (CaMKIIδB)/CREB pathway as a key regulator of MCU gene expression.

Conclusions:

• The beta-adrenergic receptor/CaMKIIδB/CREB pathway upregulates MCU expression in the heart.
• Increased MCU levels serve as a compensatory mechanism against pathological cardiac remodeling.
• Maintaining mitochondrial Ca2+ homeostasis via MCU is vital for cardiomyocyte survival and cardiac function under stress.